SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001467154-21-000156
Filing Date
2021-11-30
Accepted
2021-11-30 16:06:27
Documents
12
Period of Report
2021-11-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K novn-20211123.htm   iXBRL 8-K 40113
  Complete submission text file 0001467154-21-000156.txt   180585

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT novn-20211123.xsd EX-101.SCH 1893
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT novn-20211123_lab.xml EX-101.LAB 24831
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT novn-20211123_pre.xml EX-101.PRE 13037
5 EXTRACTED XBRL INSTANCE DOCUMENT novn-20211123_htm.xml XML 11242
Mailing Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703 919-485-8080
Novan, Inc. (Filer) CIK: 0001467154 (see all company filings)

IRS No.: 204427682 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37880 | Film No.: 211459762
SIC: 2834 Pharmaceutical Preparations